Interestingly, the regulation by Bcl-2, but not Bcl-xL, of a large number of genes associated with the Hippo pathway, was confirmed in different tumor histotypes, such as breast and lung carcinoma, thus supporting the pleiotropic role of Bcl-2, acting as an important regulator of multiple and diverse cellular processes. Here, BCL2L1 is linked to neoplasm.